![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cobra Bio-Man. | LSE:CBF | London | Ordinary Share | GB0031704835 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.25 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:7232S Cobra Bio-Manufacturing PLC 02 December 2003 For Immediate Release 2 December 2003 COBRA BIOMANUFACTURING PLC Board Appointment Cobra Biomanufacturing Plc, the international manufacturer of biopharmaceuticals, today announces the appointment of Michael Gatenby to the Board as a non-executive director. Michael graduated with Honours in Law from Cambridge. He is a chartered accountant and was a director of Hill Samuel and Co and Vice Chairman of Charterhouse Bank. He is currently a director of Johnson Service Group Plc, Porvair Plc, SRS Technology Group Plc and Protherics Plc and he is also a Trustee/Director of the Stroke Association. Michael Gatenby has been a Director of the following companies within the last five years: Former directorships (and year of resignation): 1980 Bridport plc (resigned 1999 following takeover) 1996 SGB Group plc (resigned 2000 following takeover) 1997 Powell Duffryn plc - Vice-Chairman (resigned following takeover 2000) 1999 Tarmac plc (resigned 2000 following takeover) There are no further matters to be disclosed in accordance with paragraph 'f' of schedule 2 of the AIM rules. Commenting on the appointment, Peter Fothergill, Chairman commented: "I am delighted that Michael has agreed to join the Board at this exciting time as his background and experience can make a real contribution to the challenges ahead." - ENDS - For further information, please contact: Cobra Biomanufacturing Plc Tel: +44 (0) 1782 714 181 David Thatcher, Chief Executive Officer Buchanan Communications Tel: +44 (0) 207 466 5000 Mark Court/Rebecca Skye Dietrich This information is provided by RNS The company news service from the London Stock Exchange END BOAKGMGZRMRGFZM
1 Year Cobra Bio-manufacturing Chart |
1 Month Cobra Bio-manufacturing Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions